There is a strong trend toward an increased patient-centric approach within the pharma industry. How will this trend drive the direction of cold chain for life sciences in the in the upcoming months and years?
A small sized pharmaceutical company was approaching the final phases of a large phase III global multiple treatment arm oncology study that involved comparator drug. The study criteria required the client to provide study medication to patients active at the conclusion of the study until the drug would be commercially available, when it could then be prescribed to patients continuing treatment.
The global pharmaceutical sector is embarking on a transformational journey in which the supply chain will play an increasing strategic role. There will be a need for greater agility and speed to market.
To maintain the proper temperature of vaccines, West Pediatrics relies on Onset InTemp CX400 Series VFC data loggers for accurate and reliable temperature monitoring.
Europe and the United States are considered the world leaders in the safest pharmaceutical markets for patients. However, the US and Europe are also a lucrative target for drug crime.
For most pharmaceutical companies, a key challenge is the ability to create and maintain an innovative and competitive distribution channel strategy.
The next milestone for manufacturers, November 27, 2017, is the date by which pharmaceutical manufacturers are required to print a unique product identification code on all Rx units of sale and homogenous cases distributed domestically.
Together, the InTemp CX500 data logger, InTemp mobile app, and InTempConnect cloud-based data warehousing service offer a seamless temperature-monitoring solution for Good Distribution Practices in the pharmaceutical supply chain.
The InTemp CX400 Series is a family of high-performance data loggers for monitoring temperatures in refrigerators, freezers, and other temperature-controlled environments. InTemp CX400 series loggers feature a large LCD display to keep tabs on current and daily min and max temperatures throughout the day.
With an internal temperature sensor and extra battery power to withstand the tough dry ice environment, the LIBERO Ti1-D single-use PDF Logger measures and records temperatures as low as -90 °C. Supports up to six alarm levels and the possibility to add shipment-specific information allows for individual configuration by the user.
liberoMANAGER is ELPRO's cold chain database built as cloud solution that centrally collects, verifies, automatically processes, and archives LIBERO PDF reports from cold chain shipments or site monitoring applications and is accessible from any location via web browser. liberoMANAGER is offered as «Software as a Service» and is operated, maintained, and updated by ELPRO. The solution is operated on a highly reliable and high-security data center (certified ISO 27001).
KoolTemp® Refrigerated Solutions are a complete line of tested and qualified small parcel-to-pallet size cold chain shippers for refrigerated applications.
Advanced Central Monitoring Software with the Most User-Friendly Alarming and Reporting Functionality
Managing an extensive network of laboratories, storage, production facilities or other assets is not an easy task. Being able to see the status of your facilities remotely from anywhere, at any time, becomes a «must have» requirement of our environmental monitoring system. The elproMONITOR software gives you this capability and provides you with total visibility.
KoolTemp® STS (Seasonal Transport Systems) frozen solutions are a full line of qualified dry ice and suppressed temperature (non dry ice) shippers. Featuring multiple sizes and selective shipping time capacities designed for your frozen shipment needs.
KoolTemp® Room Temperature Solutions are the industry’s most complete line of room temperature systems. Featuring multiple sizes and selective shipping time capacities designed for your room temperature shipment needs.
Biologic drugs, including monoclonal antibodies are revolutionizing the treatment of human diseases. There are nearly 60 antibodies that are approved and over 300 or more biologic drugs are at various stages of drug development. And with the improved efficacy and growing number of disease targets for biologic drugs, these numbers are likely to continue to increase.
Many organizations in the pharmaceutical and biopharmaceutical industries have increased their efforts in biotherapeutic drug development to remain competitive by shifting their activities away from small molecule toward biologics drug development.
Recent US and EU serialization mandates have introduced the GS1 DataMatrix barcode symbology into a much wider role in the pharmaceutical supply chain. While linear barcodes have served as identifiers for SKU- and lot-specific information, the more compact GS1 DataMatrix is now being used as the designated carrier for the greater amounts of data needed to authenticate and track each bottle and carton of prescription drug product. As the role of the DataMatrix has expanded, so has the need to read it consistently and reliably throughout the supply chain.
Antibody-drug conjugates (ADCs) have become de rigueur for pharmaceutical oncology drug development pipelines. There are more than 40 ADCs undergoing clinical trials and many more in preclinical development. Get the latest on novel protein modification platform and its application to generate ADCs, including new conjugation chemistries and linkers.
